Pharmafile Logo
Pharmafocus logo
Advanced Search

Kadcyla

Showing 5 posts of 20 posts found.

kadcyla image

NICE rejects Kadcyla

April 23, 2014
Sales and Marketing CDF, Cancer, Genentech, Kadcyla, NHS, NICE, Roche

NICE has delivered a severe blow to Roche by rejecting its breast cancer ‘smart bomb’ Kadcyla for NHS use in …

News
roche image

Kadcyla launches in UK

February 13, 2014
Sales and Marketing CDF, Cancer, Kadcyla, NHS, Roche, breast

 Roche’s Kadcyla, indicated to treat an aggressive form of breast cancer, has launched today in the UK.Kadcyla (trastuzumab emtansine) which …

News

Three new entries to Cancer Drugs Fund

February 5, 2014
Research and Development, Sales and Marketing CDF, Kadcyla, NHS, Tafinlar, UK, xofigo

Three drugs – Roche’s Kadcyla, Bayer’s Xofigo and GlaxoSmithKline’s Tafinlar – have been added to England’s Cancer Drugs Fund (CDF). …

News
Herceptin

Roche’s new Herceptin jab approved by NHS

September 25, 2013
Sales and Marketing Herceptin, Kadcyla, Roche, breast cancer

News
ema_building_face_web

CHMP recommends cancer ‘smart bomb’

September 23, 2013
Research and Development, Sales and Marketing CHMP, Cancer, EMA, Kadcyla, Roche

News

Latest content

Sanofi shares results from phase 2 trial for frexalimab in MS treatment

July 1, 2024

EMA accepts AstraZeneca’s regulatory submission for sipavibart for COVID-19 prevention

July 1, 2024

Eisai and Biogen’s Leqembi launched for Alzheimer’s treatment in China

June 28, 2024

AbbVie’s Tepkinly gains positive CHMP opinion for follicular lymphoma treatment

June 28, 2024

IDEAYA Biosciences announces first-patient-in for phase 1 clinical trial evaluating IDE397 and Trodelvy combination in MTAP-deletion bladder cancer

June 27, 2024